Physician profile
Krishna Patel
NPI 1881123875
$361.56
in general payments reported to CMS, 2019-2025
10 companies · $116 in 2025
The $116 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.52 · 2023: $13.30 · 2024: $216 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $346.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $88.84 | 2024-2025 | Zerbaxa, Dificid, Prevymis |
| La Jolla Pharmaceutical Company | $72.86 | 2024 | Giapreza, Xerava |
| Tetraphase Pharmaceuticals, INC. | $45.37 | 2025 | |
| Exact Sciences Corporation | $28.60 | 2025 | Cologuard Collection Kit |
| Alexion Pharmaceuticals, INC. | $26.25 | 2024 | Ultomiris |
| Ceribell, INC. | $24.50 | 2025 | Pocket Eeg Device |
| Smith+Nephew, INC. | $24.46 | 2024 | Collagenase Santyl |
| Janssen Pharmaceuticals, INC | $21.86 | 2024 | Xarelto |
| Circassia INC. | $15.52 | 2019 | |
| Abbott Laboratories | $13.30 | 2023 | Freestyle Libre 2 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krishna Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.